Immunological concepts of vaccine adjuvant activity

Current Opinion in Immunology

Volumn 12, Issue 4, 2000, Pages 456-463

  Schijns, Virgil Ejc ^a  

^a INTERVET INTERNATIONAL BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; VACCINE;

ADJUVANT THERAPY; DRUG ACTIVITY; HUMAN; IMMUNE RESPONSE; NONHUMAN; REVIEW; VACCINATION;

EID: 0034125081     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(00)00120-5     Document Type: Note

References (90)

1. Lafferty K.J., Cunningham A.J. A new analysis of allogenic interactions Austr J Exp Biol Med Sci. 53:1975;27-42.
2. Zinkernagel R.M., Ehl S., Aichele P., Oehen S., Kundig T., Hengarten H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity Immunol Rev. 156:1997;199-209.
3. Janeway C.A. Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 13:1992;11-16.
4. Matzinger P. Tolerance, danger and the extended family Annu Rev Immunol. 12:1994;991-1045.
5. Gupta R.K., Relyveld E.D., Lindblad E.B., Bizzini B., Ben-Efraim S., Gupta C.K. Adjuvants - a balance between toxicity and adjuvanticity Vaccine. 11:1993;293-306.
6. Janeway C.A. Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol. 54:1989;1-13.
7. Mackay C.R. Homing of naive, memory and effector lymphocytes Curr Opin Immunol. 5:1993;423-427.
8. Butcher E.C., Picker L.J. Lymphocyte homing and homeostasis Science. 272:1996;60-66.
9. Bachmann M.F., Zinkernagel R.M., Oxenius A. Immune responses in the absence of costimulation: viruses know the trick J Immunol. 161:1998;5791-5794.
10. -/-) mutant mice J Exp Med. 185:1997;2157-2170.
11. Kurts C., Heath W.R., Carbone F.R., Allison J., Miller J.F.A.P., Kosaka H. Constitutive class-I restricted exogenous presentation of self antigens in vivo J Exp Med. 184:1996;923-930.
12. Frey J.R., Wenk P. Experimental studies on the pathogenesis of contact eczema in the guinea pig Int Arch Allergy. 11:1957;81-100.
13. Barker C.F., Billingham R.E. The role of regional lymphatics in the skin homograft response Transplantation. 5:1967;962-975.
14. Lascelles A.K., Eagleson G., Beh K.J., Watson D.L. Significance of Freund's adjuvant/antigen injection granuloma in the maintenance of serum antibody response Vet Immunol Immunopathol. 22:1989;15-27.
15. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity Nature. 392:1998;245-252.
16. Steinman R.M., Metlay J., Bhardwaj N., Freudenthal P., Langhoff E., Crowly M., Lau L., Witmer-Pack M., Young J.W., Pure E.et al. Dendritic cells: nature's adjuvant. Janeway C.A. Jr., Sercarz E.E., Sprent J. Immunogenicity. 1998;155-165 Alan R Liss/John Wiley, New York.
17. Austyn J.M. Dendritic cells: nature's adjuvants. Gregoriadis G., McCormack B., Allison A.C., Poste G. New Generation Vaccines. The Role of Basic Immunology. 1993;1-10 Plenum Press Life Sciences, New York.
18. Roake J.A., Rao A.S., Morris P.J., Larsen C.P., Hankins D.F., Austyn J.M. Dendritic cell loss from nonlymphoid tissue after systemic administration of lipopolysaccharide, tumour necrosis factor, and interleukin 1 J Exp Med. 181:1995;2237-2247.
19. De Smedt T., Pajak B., Muraille E., Lespagnard L., Heinen E., De Baetselier P., Urbain J., Leo O., Moser M. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo J Exp Med. 184:1996;1413-1424.
20. Guéry J-G., Ria F., Adorini L. Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med. 183:1996;751-757.
21. Dupuis M., Murphy T.J., Higgins D., Ugozzoli M., van Nest G., Ott G., McDonald D.M. Dendritic cells internalize vaccine adjuvant after intramuscular injection Cell Immunol. 186:1998;18-27.
22. McWilliam A.S., Napoli S., Marsh A.M., Pemper F.L., Nelson D.J., Pimm C.L., Stumbles P.A., Wells T.N.C., Holt P.G. Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli J Exp Med. 184:1996;2429-2432.
23. Jacobson E.B., Thorbecke G.J. The proliferative and anamnestic antibody response of rabbit lymphoid cells in vitro. I. Immunological memory in the lymph nodes draining and contralateral to the site of primary antigen injection. J Exp Med. 130:1969;287-297.
24. Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity. Immunol Today. 19:1998;448-454.
25. Pulendran B., Smith J.L., Caspary G., Brasel K., Pettit D., Maraskovsky E., Maliszewski C.R. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proc Natl Acad Sci USA. 96:1999;1036-1041.
26. Gregoriadis G. Immunological adjuvants: a role for liposomes Immunol Today. 11:1990;89-97.
27. Tew J.G., Phipps R.P., Mandel T.E. The maintenance and regulation of the humoral immune response: persisting antigen and the role of follicular antigen-binding dendritic cells as accessory cells Immunol Rev. 53:1980;175-201.
28. Humphrey J.H., Frank M.M. The localization of non-microbial antigens in the draining lymph nodes of tolerant, normal and primed rabbits Immunology. 13:1967;87-100.
29. Freund J., Casals J., Page Hosmer E. Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil Proc Soc Exp Biol Med. 37:1937;509-513.
30. Caux C., Liu Y.-J., Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells Immunol Today. 16:1995;2-4.
31. Freund J. The mode of action of immunologic adjuvants Adv Tuberc Res. 7:1956;130-147.
32. 26AL Vaccine. 15:1997;1314-1318.
33. Askonas B.A., Humphrey J.H. Formation of specific antibodies and γ-globulin in vitro. A study of the synthetic ability of various tissues from rabbits immunized by different methods. Biochem J. 68:1958;252-261.
34. Pape K.A., Kearney E.R., Khoruts A., Mondino A., Merica R., Chen Z.-M., Inguli E., White J., Johson J.G., Jenkins M.K. Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cells for the study of T-cell activation in vivo Immunol Rev. 156:1997;67-78.
35. Janeway C. Immunogenicity signals 1,2,3 and 0 Immunol Today. 10:1989;283-286.
36. Janeway C.A. Jr., Goodnow H.G., Medzhitov R. Immunological tolerance: danger - pathogen on the premises! Curr Biol. 6:1996;519-522.
37. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response Science. 272:1996;50-54.
38. Parish C.R., O'Neill E.R Dependence of the adaptive immune response on innate immunity. Some questions answered but new paradoxes emerge. Immunol Cell Biol. 75:1997;523-527.
39. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
40. Medzhitov R., Janeway C.A. Jr. Innate immunity: the virtues of a nonclonal recognition system. Cell. 91:1997;295-298.
41. Rook G.A.W. New meanings for an old word: adjuvanticity, cytokines and T cells Immunol Today. 14:1993;95-96.
42. Dempsey P.W., Allison M.E.D., Akkaraja S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity Science. 271:1994;348-350.
43. Bachmann M.F., Hoffmann Rohrer U., Kundig T.M., Burki K., Hengarten H., Zinkernagel R.M. The influence of antigen organization on B cell responses Science. 262:1993;1448-1451.
44. Bachmann M.F., Zinkernagel R.M. The influence of virus structure on antibody responses and virus serotype formation Immunol Today. 17:1996;553-558.
45. Szomolanyi-Tsuda E., Le Q.P., Garcea R.L., Welsh R.M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles J Virol. 72:1998;6665-6670.
46. Villacres-Eriksson M., Behboudi S., Morgan A.J., Trinchieri G., Morein B. Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin-12 and its effects on the antibody response Cytokine. 9:1997;73-82.
47. Whitmire J.K., Slifka M.K., Grewal I.S., Flavell R.A., Ahmed R. CD40 ligand deficient mice generate a normal primary cytotoxic T-lymphocyte response but a defective humoral response to viral infection J Virol. 70:1996;8375-8381.
48. Borrow P., Tishon A., Lee S., Xu J., Grewal I.S., Oldstone M.B.A., Flavell R.A. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response J Exp Med. 183:1996;2129-2142.
49. Kawabe T., Naka T., Yoshida K., Tanak T., Fujiwara H., Suematsu S., Yoshida N., Kishimoto T., Kikutani H. The immune response in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation Immunity. 1:1994;167-178.
50. Renshaw B.R., Fanslow W.C. II., Armitage R.J., Campbell K.A., Liggitt D., Wright B., Davison B.L., Maliszweski C.R. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med. 180:1994;1889-1900.
51. Kündig T.M., Shahinian A., Kawai K., Mittrücker H-W., Sebzda E., Bachmann M.F., Mak T.W., Ohasi P.S. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity. 51:1996;41-52.
52. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Hathcock K.S., Laszlo G., McKnight A.J., Kim J., Du L., Lombard D.B.et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice Science. 262:1993;907-909.
53. Tad Y., Nagasawa K., Ho A., Morito F., Ushiyama O., Suzuki N., Ohta H., Mak T. CD28-deficient mice are highly resistant to collagen-induced arthritis J Immunol. 162:1999;203-208.
54. Shahinian A., Pfeffer K., Lee K.P., Kundig T.M., Kishihara K., Wakeman A., Kawai K., Ohashi P.S., Thompson C.B., Mak T.W. Differential T cell costimulatory requirements in CD28-deficient mice Science. 261:1993;609-612.
55. Bachmann M.F., Wong B.R., Josien R., Steinman R.M., Oxenius A., Choi Y. TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation J Exp Med. 189:1999;1025-1031.
56. Herbert W.J. The mode of action of mineral-oil emulsion adjuvants on antibody production in mice Immunology. 14:1968;301-318.
57. Van der Heijden P.H.J., Bokhout B.A., Bianchi A.T.J., Scholten J.W., Stok W. Separate application of adjuvant and antigen: the effect of a water-in-oil emulsion on the splenic plaque-forming cell response to sheep red blood cells in mice. Immunobiology. 171:1986;143-154.
58. Dresser D.W. Effectiveness of lipid and lipodophilic substances as adjuvants Nature. 191:1961;1169-1171.
59. Torres C.A.T., Iwasaki A., Barber B.H., Robinson H. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations J Immunol. 158:1997;4529-4532.
60. Ridge J.P., Fuchs E.J., Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells Science. 271:1996;1723-1726.
61. Pennisi E. Teetering on the brink of danger Science. 271:1996;1665-1667.
62. Gallucci S., Lolkema M., Matzinger P. Natural adjuvants: endogenous activators of dendritic cells Nat Med. 5:1999;1249-1255.
63. Colaco C.A.L.S. Towards a unified theory of immunity: dendritic cells, stress proteins and antigenic capture. Cell Mol Biol. 44:1998;883-890.
64. Suto R., Srivastava P. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides Science. 269:1995;1585-1588.
65. Anthony L.S.D., Wu H., Sweet H., Turnnir C., Boux L.J., Mizzen L.A. Priming of CD8+ CTL effector cells in mice by immunization with a stress protein-influenza nucleoprotein fusion molecule Vaccine. 17:1999;373-383.
66. Straw B.E., MacLachlan N.J., Corbett W.T., Carter P.B., Schey H.M. Comparison of tissue reactions produced by Haemophilus pleuropneumonia vaccines made with six different adjuvants in swine Can J Comp Med. 49:1985;149-151.
67. Yamanaka M., Hiramatsu K., Hirahara T., Okabe T., Nakai M., Sasaki N., Goto N. Pathological studies on local tissue reactions in guinea pigs and rats caused by four different adjuvants J Vet Med Sci. 54:1992;685-692.
68. Goto N., Kato H., Maeyama J., Shibano M., Saito T., Yamaguchi J., Yoshihara S. Local tissue irritating effects and adjuvant activities of calcium phosphate and aluminium hydroxide with different physical properties Vaccine. 15:1997;1364-1371.
69. 3C) conjugates. J Pathol. 164:1991;265-271.
70. Kim J.J., Bagarazzi M.L., Trivedi N., Hu Y., Kazahaya K., Wilson D., Ciccarelli R., Chattergoon M.A., Dang K., Mahalingam S.et al. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes Nat Biotech. 15:1997;641-646.
71. Chen L., Ashe S., Brady W.A., Hellström I., Hellström K.E., Ledbetter J.A., McGowan P., Linsley P.S. Costimulation of antitumor immunity by B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell. 71:1992;1093-1102.
72. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction Nature. 392:1998;408-410.
73. Bomford R. Will adjuvants be needed for vaccines of the future? Dev Biol Stand. 92:1998;13-17.
74. Rothel J.S., Corner L.A., Lightowlers M.W., Deow H.-F., McWaters P., Entrican G., Wood P.R. Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants Vet Immunol Immunopathol. 63:1998;167-183.
75. Watson D.L., Lövgren K., Watson W.A., Fossum C., Morein B., Höglund S. Inflammatory response and antigen localization following immunization with influenza virus iscoms. Inflammation. 13:1989;641-649.
76. Romani L., Bistoni F., Puccetti P. Initiation of helper cell immunity to Candida albicans by IL-12: the role of neutrophils Chem Immunol. 68:1997;110-135.
77. Vieira P.L., Kalinski P., Wierenga E.A., Kapsenberg M.L., De Jong E.C. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential J Immunol. 161:1998;5245-5251.
78. Curtsinger J.M., Schmidt C.S., Modino A., Lins D.C., Kedl R.M., Jenkins M.C., Mescher M.F. Inflammatory cytokines provide a third signal for activation of naïve CD4+ and CD8+ T cells J Immunol. 162:1999;3256-3262.
79. Nohria A., Rubin R.H. Cytokines as potential vaccine adjuvants Biotherapy. 7:1994;261-269.
80. Iwasaki A., Stiernholm B.J.N., Chan A.K., Berinstein N.L., Barber B.H. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines J Immunol. 158:1997;4591-4601.
81. Maecker H.T., Umetsu D.T., Dekruyff R.H., Levy S. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin Vaccine. 15:1997;1687-1696.
82. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice J Exp Med. 180:1998;1243-1250.
83. Brewer J.M., Conacher M., Gaffney M., Douglas M., Bleuthmann H., Alexander L. Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant Immunology. 93:1998;41-48.
84. Bromander A.K., Ekman L., Kopf M., Nedrud J.G., Lycke N.Y. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection J Immunol. 156:1996;4290-4297.
85. Samoilova E.B., Horton J.L., Hilliard B., Liu T.-S.T., Chen Y. IL-6 deficient mice are resistant to experimental autoimmune encephalitis: roles of IL-6 in the activation and differentiation of autoreactive T cells J Immunol. 161:1998;6480-6486.
86. Smith R.E., Donachie A.M., Grdic D., Lycke N., Mowat A.M. Immune-stimulating complexes induce an IL-12-dependent cascade of innate immune responses J Immunol. 162:1999;5536-5546.
87. Brewer J.M., Conacher M., Satokar A., Bluethman H., Alexander J. In interleukin-4-deficient mice, alum not only generates T helper 1 responses equivalent to Freund's complete adjuvant, but continues to induce T helper 2 cytokine production Eur J Immunol. 26:1996;2062-2066.
88. Smith R.E., Donachie A.M., McLaren F.H., Mowat A.M. Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-γ Immunology. 93:1998;556-562.
89. Vaccine supplement. Nat Med. 4:1998;474-534.
90. Souza C.R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas J Exp Med. 186:1997;1819-1829.